SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Life Scienc - Quaterly Results

21 Oct 2022 Evaluate
Net sales declined -9.34%  to  Rs. 5092.99 million from Rs. 5617.61 millions.Net profit declined -7.22% to Rs. 1068.78 millions from Rs. 1152.01 millions.Operating Profit reported a sharp decline to 1536.59 millions from 1694.26 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5092.99 5617.61 -9.34 9991.69 10866.58 -8.05 21232.14 18851.65 12.63
Other Income 100.20 20.89 379.66 195.13 60.75 221.20 147.04 8.11 1713.07
PBIDT 1536.59 1694.26 -9.31 3099.20 3338.60 -7.17 6307.64 5918.85 6.57
Interest 1.33 72.26 -98.16 2.68 277.76 -99.04 279.62 875.47 -68.06
PBDT 1535.26 1622.00 -5.35 3096.52 3060.84 1.17 6028.02 5043.38 19.52
Depreciation 99.35 96.65 2.79 198.14 185.84 6.62 378.77 333.94 13.42
PBT 1435.91 1525.35 -5.86 2898.38 2875.00 0.81 5649.25 4709.44 19.96
TAX 367.13 373.34 -1.66 742.27 713.86 3.98 1462.01 1193.63 22.48
Deferred Tax 28.20 7.91 256.51 41.05 26.00 57.88 85.74 66.17 29.58
PAT 1068.78 1152.01 -7.22 2156.11 2161.14 -0.23 4187.24 3515.81 19.10
Equity 245.05 245.05 0.00 245.05 245.05 0.00 245.05 19.60 1150.26
PBIDTM(%) 30.17 30.16 0.04 31.02 30.72 0.96 29.71 31.40 -5.38

Alivus Life Sciences Share Price

1062.55 -4.10 (-0.38%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×